Parvulet(R) Technology - Patient Centric Dosing Solution

Parvulet(R) Technology - Patient Centric Dosing Solution

Products
Parvulet(R) Technology - Patient Centric Dosing Solution
Parvulet(R) Technology - Patient Centric Dosing Solution

Information

Adare has recently launched a new patient centric dosage solution, the Parvulet TM Technology. The Parvulet TM Technology enables a solid powder or tablet to convert to a semi-solid in the presence of water within thirty seconds. The final dosage is easily administered, as a soft food like texture, ideal for pediatric and geriatric populations (including those with dysphagia).
Main Categories
Contract Services - Analytical & Lab ServicesPharmaceutical Machinery & Technology
Available In
North America (USA, Canada)Central America (e.g. Mexico)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)
All Categories
Contract ManufacturingContract Services - Analytical & Lab ServicesFormulation developmentPharmaceutical Machinery & TechnologyControlled, customized or modified drug release
Supplied From
United States
Adare Pharma SolutionsAdare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with small molecule expertise focusing on oral dosage forms. Adare's specialized technology platforms provide taste masking, customized release, solubility enhancement, and patient-centric dosing solutions. With a proven history in drug delivery, Adare's seven facilities in the US and Europe have developed and manufactured more than 65 products sold by customers worldwide.

Log in

See all the content and easy-to-use features by logging in or registering!